Collplant Holdings Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
CLGN
IL0004960188
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- ILa | -.--% | -14.91% | -.--% |
Sales 2024 * | 10.53M 2.82M 1.05B 3.89M | Sales 2025 * | 53.98M 14.46M 5.4B 19.91M | Capitalization | 251M 67.32M 25.14B 92.72M |
---|---|---|---|---|---|
Net income 2024 * | -60M -16.07M -6B -22.13M | Net income 2025 * | -24M -6.43M -2.4B -8.85M | EV / Sales 2024 * | 23.9 x |
Net cash position 2024 * | - 0 0 0 | Net cash position 2025 * | - 0 0 0 | EV / Sales 2025 * | 4.66 x |
P/E ratio 2024 * |
-4.14
x | P/E ratio 2025 * |
-10.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.27% |
Managers | Title | Age | Since |
---|---|---|---|
Yehiel Tal
CEO | Chief Executive Officer | 71 | 09-12-31 |
Oded Shoseyov
FOU | Founder | 67 | 04-05-31 |
Eran Rotem
DFI | Director of Finance/CFO | 56 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Avri Havron
BRD | Director/Board Member | 76 | 16-04-30 |
Hugh Evans
BRD | Director/Board Member | 58 | 21-03-28 |
Elan Penn
BRD | Director/Board Member | 72 | 17-12-31 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.76% | 924M | |
-19.12% | 130M | |
+6.78% | 60.11M | |
+1.80% | 52.22M |
- Stock Market
- Equities
- CLGN Stock
- CLGN Stock